Assessment of thermal sensitivity in rats using the thermal place preference test: Description and application in the study of oxaliplatin-induced acute thermal hypersensitivity and inflammatory pain models

Behavioural Pharmacology

Volumn 25, Issue 2, 2014, Pages 99-111

  Balayssac, David ^a,b,c   Ling, Bing ^a,b   Ferrier, Jérémy ^a,b   Pereira, Bruno ^c   Eschalier, Alain ^a,b,c   Authier, Nicolas ^a,b,c  

^a INSERM U1107 NEURO DOL Faculties of Medicine and Pharmacy ^*  (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

carrageenan; duloxetine; morphine; neuropathy; oxaliplatin; rat; thermal place preference test; thermal sensitivity

Indexed keywords

CARRAGEENAN; DIAZEPAM; DULOXETINE; MORPHINE; OXALIPLATIN; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT; PLATINUM COMPLEX; THIOPHENE DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; COLD SENSITIVITY; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL MODEL; HEAT SENSITIVITY; HYPERSENSITIVITY; INFLAMMATORY PAIN; MALE; MOTOR COORDINATION; NEUROPATHIC PAIN; NONHUMAN; PATHOPHYSIOLOGY; PLACE PREFERENCE; RAT; ROTAROD TEST; SENSITIVITY AND SPECIFICITY; TEMPERATURE SENSITIVITY; THERMAL PLACE PREFERENCE TEST; ANIMAL; COLD; CONDITIONING; DEPTH PERCEPTION; DISEASE MODEL; DRUG EFFECTS; HEAT; HYPERALGESIA; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PROCEDURES; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; TEMPERATURE; VALIDATION STUDY;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; COLD TEMPERATURE; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HOT TEMPERATURE; HYPERALGESIA; MALE; MORPHINE; ORGANOPLATINUM COMPOUNDS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SPACE PERCEPTION; TEMPERATURE; THIOPHENES;

EID: 84896389885     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000026     Document Type: Article

References (29)

1. Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepère C, et al. (2009). Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 144:245-252.
2. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F (2000). Description of a short-term taxol-induced nociceptive neuropathy in rats. Brain Res 887: 239-249.
3. Bardin L, Gregoire S, Aliaga M, Malfetes N, Vitton O, Ladure P, et al. (2010). Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. Neurosci Res 66:135-140.
4. Berge OG (2011). Predictive validity of behavioural animal models for chronic pain. Br J Pharmacol 164:1195-1206.
5. Bomholt SF, Mikkelsen JD, Blackburn-Munro G (2005). Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48:252-263.
6. Carlson JN, Haskew R, Wacker J, Maisonneuve IM, Glick SD, Jerussi TP (2001). Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. Eur J Pharmacol 415:181-189.
7. Chakrabarty A, McCarson KE, Smith PG (2011). Hypersensitivity and hyperinnervation of the rat hind paw following carrageenan-induced inflammation. Neurosci Lett 495:67-71.
8. Costa B, Colleoni M, Conti S, Parolaro D, Franke C, Trovato AE, Giagnoni G (2004). Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 369:294-299.
9. Girard P, Pansart Y, Gillardin JM (2004). Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat. Pharmacol Biochem Behav 77:695-703.
10. Jones CK, Peters SC, Shannon HE (2005). Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther 312: 726-732.
11. Joseph EK, Chen X, Bogen O, Levine JD (2008). Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9:463-472.
12. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010). Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 29:e1000412.
13. Le Bars D, Gozariu M, Cadden SW (2001). Animal models of nociception. Pharmacol Rev 53:597-652.
14. Ling B, Coudoré-Civiale MA, Balayssac D, Eschalier A, Coudoré F, Authier N (2007). Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Toxicology 234: 176-184.
15. Lunn MP, Hughes RA, Wiffen PJ (2009). Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 7:CD007115.
16. Martin TJ, Buechler NL, Kahn W, Crews JC, Eisenach JC (2004). Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 101:191-203.
17. Millecamps M, Jourdan D, Leger S, Etienne M, Eschalier A, Ardid D (2005). Circadian pattern of spontaneous behavior in monarthritic rats: a novel global approach to evaluation of chronic pain and treatment effectiveness. Arthritis Rheum 52:3470-3478.
18. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, et al. (2005). Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307:1468-1472.
19. Morgan D, Mitzelfelt JD, Koerper LM, Carter CS (2011). Effects of morphine on thermal sensitivity in adult and aged rats. J Gerontol A Biol Sci Med Sci 67:705-713.
20. Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, et al. (2003). Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306: 490-497.
21. Pincedé I, Pollin B, Meert T, Plaghki L, Le Bars D (2012). Psychophysics of a nociceptive test in the mouse: ambient temperature as a key factor for variation. PLoS One 7:e36699.
22. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359-1367
23. National Academy of Sciences (2011). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: National Academy of Sciences.
24. Vierck CJ, Hansson PT, Yezierski RP (2008). Clinical and pre-clinical pain assessment: are we measuring the same thing? Pain 135:7-10.
25. Winter CA, Risley EA, Nuss GW (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544-547.
26. Yalcin I, Charlet A, Freund-Mercier MJ, Barrot M, Poisbeau P (2009). Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents. J Pain 10:767-773.
27. Yang YH, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, et al. (2011). Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Support Care Cancer 20:1491-1497.
28. Yu LC, Hansson P, Lundeberg S, Lundeberg T (1998). Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation. Eur J Pharmacol 347:275-282.
29. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.